Franchini Indrani Lall
Insider CIK 1708764 · ALNY EVP, CLO & Secretary · AVNS Director · ALXN EVP, Chief Compliance Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AVNS AVANOS MEDICAL, INC. | D To issuer deriv | 2026-07-27 | 2026-07-28 | 12,003 | $25.00 | $300.1K | 0 | SEC↗ |
| AVNS AVANOS MEDICAL, INC. | D To issuer | 2026-07-27 | 2026-07-28 | 4,817 | $25.00 | $120.4K | 0 | SEC↗ |
| AVNS AVANOS MEDICAL, INC. | D To issuer deriv | 2026-07-27 | 2026-07-28 | 12,003 | $25.00 | $300.1K | 0 | SEC↗ |
| AVNS AVANOS MEDICAL, INC. | D To issuer | 2026-07-27 | 2026-07-28 | 4,817 | $25.00 | $120.4K | 0 | SEC↗ |
| AVNS AVANOS MEDICAL, INC. | A Award deriv | 2026-05-08 | 2026-05-12 | 12,003 | — | $0 | 12,003 | SEC↗ |
| AVNS AVANOS MEDICAL, INC. | A Award | 2025-01-02 | 2025-01-06 | 12,003 | — | $0 | 16,820 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 66 | $156.38 | $10.3K | 4,143 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 111 | $155.45 | $17.3K | 4,209 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 142 | $154.54 | $21.9K | 4,320 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 1 | $158.09 | $158 | 4,133 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-28 | 2024-02-29 | 9 | $157.30 | $1.4K | 4,134 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2024-02-27 | 2024-02-29 | 878 | — | $0 | 1,754 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2024-02-27 | 2024-02-29 | 878 | — | $0 | 4,462 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-02 | 2024-02-05 | 269 | $172.38 | $46.4K | 3,584 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-02 | 2024-02-05 | 820 | $171.14 | $140.3K | 3,853 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2024-02-02 | 2024-02-05 | 502 | $170.01 | $85.3K | 4,673 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2024-02-01 | 2024-02-05 | 5,175 | — | $0 | 5,175 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2024-02-01 | 2024-02-05 | 5,175 | — | $0 | 5,175 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-04-06 | 2023-04-10 | 3,500 | $210.00 | $735.0K | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2023-02-27 | 2023-03-01 | 5,449 | — | $0 | 5,449 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2023-02-27 | 2023-03-01 | 2,632 | — | $0 | 2,632 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-02-02 | 2023-02-03 | 5 | $227.38 | $1.1K | 3,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-02-02 | 2023-02-03 | 77 | $223.97 | $17.2K | 5,098 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-02-02 | 2023-02-03 | 1,007 | $225.80 | $227.4K | 4,091 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2023-02-02 | 2023-02-03 | 586 | $226.62 | $132.8K | 3,505 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2023-02-01 | 2023-02-03 | 5,175 | — | $0 | 10,350 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2023-02-01 | 2023-02-03 | 5,175 | — | $0 | 5,175 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2022-02-01 | 2022-02-09 | 15,525 | — | $0 | 15,525 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2022-02-01 | 2022-02-09 | 29,182 | — | $0 | 29,182 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | D To issuer deriv | 2021-07-21 | 2021-07-23 | 25,165 | $100.14 | $2.52M | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | D To issuer | 2021-07-21 | 2021-07-23 | 116,075 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2021-07-14 | 2021-07-16 | 25,813 | — | $0 | 116,075 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2021-07-14 | 2021-07-16 | 26,812 | — | $0 | 90,262 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | F Tax w/h | 2021-06-08 | 2021-06-09 | 928 | $177.00 | $164.3K | 63,450 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2021-02-28 | 2021-03-02 | 18,033 | — | $0 | 64,378 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | F Tax w/h | 2020-12-16 | 2020-12-18 | 2,913 | $157.96 | $460.1K | 46,345 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2020-12-16 | 2020-12-18 | 37,965 | — | $0 | 66,183 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | F Tax w/h | 2020-12-16 | 2020-12-18 | 16,925 | $157.96 | $2.67M | 49,258 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | S Sale | 2020-06-08 | 2020-06-09 | 5,420 | $114.61 | $621.2K | 29,651 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | S Sale | 2020-06-08 | 2020-06-09 | 1,433 | $115.00 | $164.8K | 28,218 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | F Tax w/h | 2020-06-08 | 2020-06-09 | 1,403 | $114.61 | $160.8K | 35,071 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | F Tax w/h | 2020-03-02 | 2020-03-03 | 1,267 | $90.54 | $114.7K | 36,474 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2020-02-28 | 2020-03-03 | 9,520 | — | $0 | 37,741 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | F Tax w/h | 2020-02-07 | 2020-02-10 | 1,406 | $102.97 | $144.8K | 28,221 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | S Sale | 2019-07-01 | 2019-07-02 | 4,500 | $132.78 | $597.5K | 29,627 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | F Tax w/h | 2019-06-07 | 2019-06-11 | 1,404 | $118.61 | $166.5K | 34,127 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | F Tax w/h | 2019-02-28 | 2019-03-04 | 625 | $132.93 | $83.1K | 27,281 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | A Award | 2019-02-28 | 2019-03-05 | 8,250 | — | $0 | 35,531 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | F Tax w/h | 2019-02-07 | 2019-02-11 | 1,398 | $119.57 | $167.2K | 27,906 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS, I | S Sale | 2018-11-28 | 2018-11-30 | 2,605 | $118.13 | $307.7K | 29,304 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2018-06-08 | 2018-06-12 | 1,466 | $118.53 | $173.8K | 31,909 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2018-02-28 | 2018-03-02 | 8,344 | — | $0 | 33,375 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2018-02-08 | 2018-02-08 | 1,459 | $116.31 | $169.7K | 25,031 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2018-02-06 | 2018-02-08 | 13,908 | — | $0 | 26,490 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award deriv | 2017-06-07 | 2017-06-09 | 25,165 | — | $0 | 25,165 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | A Award | 2017-06-07 | 2017-06-09 | 12,582 | — | $0 | 12,582 | SEC↗ |